2011 Pharmacist's Guide to Skin Health: AcneFor teens and adults alike, adherence, self-care essential. Clinical Notes: Drugs with adverse skeletal effectsCertain drugs can adversely affect the skeleton and increase the risk of osteoporosis or fractures. Practice Issues: The role of CETP inhibitors references What will be the likely role of cholesteryl ester transfer protein inhibitors in the management of dyslipidemia? Drug News: June 2011 Byetta: second GLP-1 agonist for diabetes; Gilenya: first oral disease-modifying drug for MS; Nucynta CR: new opioid for moderate—moderate/severe pain. Practice Issues: Research Highlights - Nitroglycerin for osteoporosis A recent study provides data on the effects of nitrates on bone in postmenopausal women. Canadians support stronger diabetes policy But those with diabetes are not getting the best care, as evidenced by the high rate of hospitalizations Drug offers oral option for MS Canadian Diabetes Association to launch compassionate use program Initiative assists people with diabetes who have difficulty covering the costs of blood glucose monitoring supplies. The pressure’s on to treat resistant hypertension Causes of this common problem in primary care may include overlooked comorbidities or unrelated medications A new view of women’s cardiovascular risks Updated guidelines consider long-term risk with wider focus beyond coronary artery disease First Previous 175 176 177 178 179 Next Last
